Table 2 Associations of serum Cu, Se, Zn, Se/Cu and Zn/Cu ratios with Sarcopenia.
From: The mediating role of inflammatory biomarkers in the association between serum copper and sarcopenia
Characteristic | Crude model | Model I | Model II | ||||||
|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | |
Cu | |||||||||
Q1 (43.9–101.7) | Ref | Ref | – | Ref | Ref | – | Ref | Ref | – |
Q2 (101.7–123.2) | 2.73 | 1.81, 4.13 | < 0.001 | 2.96 | 1.88, 4.65 | < 0.001 | 3.02 | 1.85, 4.91 | < 0.001 |
Q3 (123.2–289.8) | 3.25 | 2.13, 4.98 | < 0.001 | 4.62 | 2.62, 8.15 | < 0.001 | 3.38 | 1.82, 6.26 | < 0.001 |
Se | |||||||||
Q1 (80.5–121.7) | Ref | Ref | – | Ref | Ref | – | Ref | Ref | – |
Q2 (80.5–135.4) | 1.06 | 0.70, 1.61 | 0.778 | 1.01 | 0.66, 1.53 | 0.974 | 0.86 | 0.52, 1.42 | 0.546 |
Q3 (135.4–299.1) | 1.18 | 0.71, 1.96 | 0.528 | 1.07 | 0.64, 1.79 | 0.795 | 1.09 | 0.63, 1.87 | 0.745 |
Zn | |||||||||
Q1 (44.0–75.5) | Ref | Ref | – | Ref | – | – | Ref | Ref | – |
Q2 (75.5–87.6) | 0.82 | 0.52, 1.31 | 0.407 | 0.81 | 0.50, 1.31 | 0.387 | 0.84 | 0.47, 1.51 | 0.542 |
Q3 (87.6–232.5) | 1.00 | 0.62, 1.61 | 0.995 | 1.02 | 0.63, 1.67 | 0.921 | 1.02 | 0.57, 1.80 | 0.952 |
Se/Cu | |||||||||
Q1 (0.46–1.03) | Ref | Ref | – | Ref | Ref | – | Ref | Ref | – |
Q2 (1.03–1.29) | 0.79 | 0.54, 1.16 | 0.222 | 0.64 | 0.40, 1.05 | 0.074 | 0.88 | 0.55, 1.39 | 0.557 |
Q3 (1.29–4.93) | 0.42 | 0.27, 0.67 | < 0.001 | 0.30 | 0.16, 0.56 | < 0.001 | 0.45 | 0.23, 0.89 | 0.023 |
Zn/Cu | |||||||||
Q1 (0.19–0.64) | Ref | Ref | – | Ref | Ref | – | Ref | Ref | – |
Q2 (0.64–0.82) | 0.77 | 0.53, 1.11 | 0.157 | 0.65 | 0.42, 1.00 | 0.050 | 0.92 | 0.60, 1.42 | 0.702 |
Q3 (0.82–3.08) | 0.42 | 0.26, 0.69 | < 0.001 | 0.35 | 0.20, 0.61 | < 0.001 | 0.49 | 0.27, 0.90 | 0.024 |
